Key statistics
On Friday, Day One Biopharmaceuticals Inc (DAWN:NSQ) closed at 11.41, -13.56% below its 52-week high of 13.20, set on Jan 21, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 11.06 |
|---|---|
| High | 11.50 |
| Low | 10.84 |
| Bid | 10.99 |
| Offer | 11.65 |
| Previous close | 10.48 |
| Average volume | 1.99m |
|---|---|
| Shares outstanding | 102.68m |
| Free float | 85.28m |
| P/E (TTM) | -- |
| Market cap | 1.08bn USD |
| EPS (TTM) | -1.48 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 21:00 GMT.
More ▼
- Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
- Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
- Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases
- Day One Announces New OJEMDA™ (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
- Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
- Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
- Day One Reports Second Quarter 2025 Financial Results and Corporate Progress
- Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
- Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development
More ▼
